|
PF-56712 |
LABRIXILE ER 0.75, 0.75 mg Comprimido de liberación prolongada |
2024-05-16 |
|
Roemmers de Centroamerica, S.A. |
Uruguay
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56668 |
LABRIXILE ER 1.5, 1.5 mg Comprimido de liberación prolongada |
2024-05-07 |
|
Roemmers de Centroamerica, S.A. |
Uruguay
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56713 |
LABRIXILE ER 0.375, 0.375 mg Comprimido de liberación prolongada |
2024-05-16 |
|
Roemmers de Centroamerica, S.A. |
Uruguay
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56367 |
IMUPROT 0.5 mg Comprimidos recubiertos |
2024-02-07 |
|
Megapharma Labs de Ceam, Sociedad Anónima |
Uruguay
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56268 |
LOTRIAL 20 mg Comprimidos |
2024-01-16 |
|
Mega Labs, S.A. |
Uruguay
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56278 |
CORENTEL H 5/6.25 mg Comprimido recubierto |
2024-01-17 |
|
Mega Labs, S.A. |
Uruguay
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56277 |
CORENTEL H 10/6.25 Comprimidos recubiertos |
2024-01-17 |
|
Mega Labs S.A. |
Uruguay
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56354 |
CEUMID XR 1000, 1000 mg Comprimidos recubiertos de liberación * |
2024-02-04 |
|
Megapharma Labs de Ceam, Sociedad Anónima |
Uruguay
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56659 |
CEUMID XR 750, 750 mg Comprimidos recubiertos de liberacion prolongada |
2024-05-06 |
|
Megapharma Labs de Ceam, Sociedad Anónima |
Uruguay
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56487 |
OXA 75, 75 mg/ 3 mL solución inyectable |
2024-03-20 |
|
Panalab S.A. |
Uruguay
|
Leterago |
Codalo |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|